Tenet Healthcare Corp. v. Community Health System, Inc.

839 F. Supp. 2d 869, 2012 U.S. Dist. LEXIS 38303, 2012 WL 936388
CourtDistrict Court, N.D. Texas
DecidedMarch 21, 2012
DocketCivil Action No. 3:11-CV-732-M
StatusPublished
Cited by2 cases

This text of 839 F. Supp. 2d 869 (Tenet Healthcare Corp. v. Community Health System, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tenet Healthcare Corp. v. Community Health System, Inc., 839 F. Supp. 2d 869, 2012 U.S. Dist. LEXIS 38303, 2012 WL 936388 (N.D. Tex. 2012).

Opinion

MEMORANDUM OPINION AND ORDER

BARBARA M.G. LYNN, District Judge.

Before the Court is Defendants’ Motion to Dismiss [Docket Entry # 40]. The Motion is GRANTED and Plaintiffs claims are DISMISSED with prejudice.

I. Background and Procedural History

Plaintiff Tenet Healthcare Corporation (“Tenet”) seeks a judgment against Defendants Community Health Systems, Inc. (“CHS”), Wayne T. Smith, and W. Larry Cash for its costs and disbursements incurred in connection with analyzing and opposing Defendants’ preliminary proxy materials. CHS initially attempted to acquire Tenet in a cash and stock transaction in November 2010. The Tenet Board rejected CHS’s offer and thereafter, CHS went public with its acquisition proposal. From December 2010 to May 2011, CHS made various preliminary proxy filings with the Securities and Exchange Commission (“SEC”), preparatory to potential later efforts to effectuate a merger with Tenet and nominate a slate of directors for the Tenet Board. CHS’s proxy materials [870]*870included assertions concerning the value of a CHS acquisition of Tenet and statements touting the benefits of synergies between the companies. Tenet alleges that CHS’s materials contained materially false and misleading statements and omissions, and claims it had difficulty substantiating synergies. It says it engaged in an analysis of CHS’s business, and found that its hospital admissions practices were improper, rendering the alleged synergies non-existent. Tenet contends the significant costs it incurred in analyzing CHS and its proxy solicitation materials were designed to allow it and its shareholders to fairly consider and oppose CHS’s efforts.

Tenet filed its original Complaint on April 11, 2011, seeking injunctive and declaratory relief and damages under Section 14(a) of the Securities and Exchange Act of 1934 and SEC Rule 14a~9. CHS then made additional efforts to acquire Tenet, but upon Tenet’s rejection of CHS’s final offer in May 2011, CHS withdrew its proposed slate of candidates for Tenet’s Board. Tenet then amended its Complaint to recover its costs to analyze CHS, its bids, and its proposed slate. Defendants move to dismiss under Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6).

II. Analysis

Defendants argue under Federal Rule of Civil Procedure 12(b)(1) that Tenet lacks standing under Section 14(a) to recover its costs as claimed. Defendants argue that Section 14(a) authorizes only private causes of action for shareholders with voting rights. Tenet argues that its claim for damages is brought on behalf of its voting shareholders, and that because it was in the best position to protect the voting process on their behalves, it has standing to sue.

Four opinions of the United States Supreme Court are particularly relevant to the issues presented here. In J.I. Case Co. v. Borak, the Supreme Court ruled that shareholders could assert a private action for damages and other relief under Section 14(a), either individually or in a derivative suit.1 In finding a private right of action under Section 14(a) based upon misleading statements, the Supreme Court concluded that “it is the duty of the courts to be alert to provide such remedies as are necessary to make effective the congressional purpose” behind the statute.2 Here, Tenet argues that Borah’s holding should be extended to suits brought by the target corporation in a proxy fight, since such a suit seeks to protect shareholders from incurring investigative and analytical expenses in investigating a proxy filer.

The broad language of Borak as to the duty of courts in implying a private right was addressed by the Supreme Court almost thirty years later in Virginia Bankshares Inc. v. Sandberg,3 There, the Supreme Court held that minority shareholders, whose votes were not required to effectuate the corporate action subject to the proxy solicitation, did not have standing to sue under Section 14(a).4 In so holding, the Supreme Court emphasized the importance of ascertaining congressional intent, rather than congressional purpose, in determining whether a private remedy exists.5

[871]*871The Supreme Court analyzed the legislative history of Section 14(a), noting that Congress intended to protect “fair corporate suffrage” and the “free exercise” of shareholders’ voting rights from false and misleading statements, but emphasizing that Congress had been “reticent” to articulate the extent to which it sought to protect these rights through private suits.6

Subsequent Supreme Court decisions have further narrowed the holding of Borah to its specific facts. In Alexander v. Sandoval, the Supreme Court again focused on congressional intent as a basis for finding an implied private right of action, rather than on congressional purpose as it had done in Borak.7 The Supreme Court reiterated that in Virginia Banhshares, it had already narrowed Borah’s scope. Finally, in Stmeridge Investment Partners, LLC v. Scientific-Atlanta, Inc., the Supreme Court again cautioned against judicially-created causes of action when a private right of action was not the subject of expressed congressional intent.8

Two district courts addressing the issue of whether a target corporation has standing to sue for damages under Section 14(a) have reached opposite conclusions. In Diceon Electronics v. Calvary Partners, L.P., the court concluded that granting standing to a target corporation to claim damages under Section 14(a) would impermissibly extend Borah and other case law seemingly “contrary to the legislative intent behind § 14(a).”9 The court in Diceon found that the congressional intent behind Section 14(a), to protect shareholders from misleading statements, would not be thwarted by denying a target corporation standing to sue for damages. In looking at the legislative history, the court noted that Congress enacted Section 14(a) for the benefit of shareholders, not management. The court stated that Congress intended for Section 14(a) to ensure the flow of accurate information to shareholders confronted by a proxy solicitation and was intended for situations where “corporate democracy is most likely to fail, namely, where management, unopposed, solicits proxies.” 10

Reaching a result contrary to that in Diceon, the court in International Jensen Inc. v. Emerson Radio Corp. held that a target corporation could recover its expenses in response to another party’s use of improper proxy solicitations, finding that when “a corporation incurs expenses in reaction to another party’s use of improper proxy solicitations, it is in reality the shareholders who are harmed.”11

This Court concludes, based on the focus on congressional intent mandated by Virginia Banhshares, that it cannot infer “any congressional urgency to depend on implied private actions [by target corporations] to deter violations of § 14(a)” especially through the type of damages Tenet seeks here.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
839 F. Supp. 2d 869, 2012 U.S. Dist. LEXIS 38303, 2012 WL 936388, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tenet-healthcare-corp-v-community-health-system-inc-txnd-2012.